To overcome this limitation, we analyzed TCGA data for ccRCC, pRCC, and chRCC and found that BIRC5 was significantly increased in tumors of the three major tumor subtypes compared with non-tumor tissues and that elevated expression correlated with tumor progression. The gene discussed is BIRC5; the disease is chromophobe renal cell carcinoma.